Wells Fargo analyst Mohit Bansal maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price target ...

Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to trigger sufficient levels of insulin production in a phase 1/2 trial.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vertex Pharmaceuticals (VRTX – Research Report) and Apellis ...

The pair will look to create revenue streams through content from the WTFN library, starting with a network called Real Emergency. WTFN’s broadcast distribution arm, Fred Media, will the FAST ...

HOFFMAN ESTATES, Ill., March 31, 2025 /PRNewswire/ -- Cambium Networks Corporation ("Cambium Networks" or the "Company") (NASDAQ: CMBM), a leading provider of wireless and wired networking ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

The last three months have been tough on Arista Networks Inc ( NYSE:ANET ) shareholders, who have seen the share price... Arista Networks (NYSE: ANET) stock got hit with big sell-offs Thursday as ...

A gene regulatory network is a set of genes, or parts of genes, that interact with each other to control a specific cell function. Gene regulatory networks are important in development ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...